UTA researchers uncover role of IDO1 enzyme in Cholesterol Dysregulation during inflammation
1 July 2025

UTA researchers uncover role of IDO1 enzyme in Cholesterol Dysregulation during inflammation

Researchers at the University of Texas at Arlington (UTA) have identified a novel molecular mechanism by which chronic inflammation impairs cholesterol metabolism, potentially paving the way for new therapeutic strategies targeting inflammatory diseases and cardiovascular disorders.
1 July 2025
Biological E. and Recbio partner to bring HPV9 Vaccine to India and global markets
In a significant development for global health, Hyderabad-based Biological E. Limited has joined hands with Chinese biopharmaceutical firm Jiangsu Recbio Technology Company Limited to produce and distribute the 9-valent Human Papillomavirus (HPV9) vaccine, REC603.
1 July 2025
Alembic Pharmaceuticals receives final USFDA approval for Doxorubicin Hydrochloride Liposome Injection
Alembic Pharmaceuticals Limited has announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection in two strengths: 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials.
1 July 2025
June 2025 | Openings in pharmaceutical industries and government pharmacy sectors

Christian Medical College looking for Scientist, Research Officer - Pharm.D, M.Pharm, MSc Apply
Masters in Biostatistics or Statistics or Epidemiology or Public Health or Clinical Research or Pharmacology or equivalent. Help in running the activities under the technical resource hub / Biostatistics and other clinical research areas, including conducting systematic reviews.